The Petri Dish: Moderna nabs Novartis exec as new CTO, Ginkgo acquires two companies

Biogen’s patent battles over Tecfidera are over after SCOTUS decision; Ginkgo Bioworks delves into the RNA therapeutics; and Peter Thiel invests in Waltham startup creating "humanized" mice.